Sciton Obtains FDA Clearance for Permanent Hair Reduction

Palo Alto, CA. — November 9, 2001 — Sciton, Inc., announced today that the U.S. Food and Drug Administration has cleared the IMAGE™ Longpulse Nd:YAG laser system for permanent hair reduction in skin types I-VI. Image achieves permanent hair reduction through selective targeting of melanin in hair follicles. Previously, the Image laser system was cleared by the FDA for treating hair removal and a broad range of vascular lesions.

“With the longer wavelength, deeper effects of the technology can be applied for hair removal and effectively treat dark-skinned individuals by bypassing the epidermal melanin. The 1064 wavelength is rapidly becoming recognized as the wavelength of choice for all skin types. Sciton’s unique range of parameters and efficient cooling is an enabling technology,&quote; explained Dr. Jason Pozner, who is a board-certified plastic surgeon in Boca Raton, Fl.

According to Dr. Dan Negus, President of Sciton, Inc., “We are very excited about the approval and encouraged that the FDA has cleared Image for permanent hair reduction. Sciton’s unique technology, coupled with efficient delivery system and superior epidermal cooling, provides the physician with a wide range of treatment options for patients with skin types I-IV. Efficacy, Pain Management, and Speed are the three critical elements that need to be present in a hair removal system and Image has all three. We now plan to proceed with our marketing launch and like our previous product, Contour™, fully expect this product to rapidly reach market dominance.”

In 1998, Sciton revolutionized the skin resurfacing market with the introduction of the Contour dual-mode long pulse erbium laser that allows physicians to independently select the depth of ablation and coagulation. Physicians are able to choose the depth of treatment required to achieve effective results in measurements of microns of tissue, resulting in an extremely repeatable and uniform treatment.

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United StatesCanadaJapanAustralia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.